Investors & Media
About
Our Science
Our Programs
Careers
Investors & Media
Stockholder Tools
Global - Contact
Investor Contact
Kia Khalaghpour, Ph.D.
Vice President, Investor Relations and Communications
Constellation Pharmaceuticals
+1-617-844-6859
kia.khaleghpour@constellationpharma.com
Media Contact
Lauren Arnold
MacDougall Biomedical Communications
+1-781-235-3060
larnold@macbiocom.com
Committee Composition
Audit Committee | Compensation Committee | Nominating and Corporate Governance Committee | Research and Development Committee | |
---|---|---|---|---|
James E. Audia Ph.D. | Research and Development Committee | |||
Scott Braunstein, M.D. | Audit Committee | Nominating and Corporate Governance Committee | ||
Mark A. Goldsmith, M.D., Ph.D. | Audit Committee | Compensation Committee | Nominating and Corporate Governance Committee | |
Steven L. Hoerter | Audit Committee | Nominating and Corporate Governance Committee | ||
Richard Levy, M.D | Research and Development Committee | |||
Elizabeth G. Tréhu, M.D. | Compensation Committee | Research and Development Committee |
= Chairperson
= Member
= Chairman of the Board
Investors & Media
About
Our Science
Our Programs
Careers
Investors & Media
Stockholder Tools
Investor Contact
Kia Khalaghpour, Ph.D.
Vice President, Investor Relations and Communications
Constellation Pharmaceuticals
+1-617-844-6859
kia.khaleghpour@constellationpharma.com
Media Contact
Lauren Arnold
MacDougall Biomedical Communications
+1-781-235-3060
larnold@macbiocom.com